OpGen Stock Price

0.06 (2.63%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
OpGen Inc OPGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 2.63% 2.34 15:19:32
Open Price Low Price High Price Close Price Prev Close
2.28 2.2311 2.36 2.28
Bid Price Ask Price Spread News
2.34 2.35 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,659 445,185 $ 2.32 $ 1,031,272 2,025,122 1.63 - 4.56
Last Trade Time Type Quantity Stock Price Currency
15:19:32 100 $ 2.34 USD

OpGen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 52.62M 22.49M 22.46M $ 3.50M $ - -9.52 0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

OpGen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OPGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.582.622.192.351,122,133-0.24-9.3%
1 Month2.972.992.192.591,479,621-0.63-21.21%
3 Months2.424.371.632.8312,006,980-0.08-3.31%
6 Months2.404.371.632.756,164,920-0.06-2.5%
1 Year2.344.561.632.784,992,5000.000.0%
3 Years2.1112.800.21022.742,119,6520.2310.9%
5 Years36.4975116.250.21026.551,641,217-34.16-93.59%

OpGen Description

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledgebase.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.